+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07824323

EARLY-BIRD ACS Trial Evaluating Early Triple Lipid-Lowering Therapy With Bempedoic Acid Added to High-Intensity Statin and Ezetimibe in Acute Coronary Syndrome Patients

Led by Taipei Medical University Hospital · Updated on 2026-09-17

400

Participants Needed

1

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether starting bempedoic acid in addition to high-intensity statin therapy and ezetimibe within 72 hours after percutaneous coronary intervention PCI can improve control of low-density lipoprotein cholesterol LDL-C in adults who have experienced acute coronary syndrome. This Phase 4 randomized clinical trial compares a triple therapy approach with standard dual therapy to see if more participants can achieve LDL-C levels below 55 mgdL at 12 weeks. Participants are randomly assigned to receive either triple therapy consisting of bempedoic acid 180 mg once daily, ezetimibe 10 mg once daily, and a high-intensity statin atorvastatin 40 mg or rosuvastatin 20 mg daily or dual therapy with ezetimibe and a high-intensity statin alone. Treatment starts within 72 hours after PCI and continues for 12 weeks. Follow-up assessments occur at Week 4 and Week 12, with laboratory tests performed using standardized methods. During the study, participants will have blood tests to measure LDL-C, high-sensitivity C-reactive protein, and other lipid and inflammatory markers. Researchers will monitor medication adherence and track any treatment-emergent adverse events, including muscle-related issues, liver enzyme levels, hyperuricemia, gout symptoms, and gallbladder events. The primary outcome is the proportion of participants achieving LDL-C below 55 mgdL at Week 12. The total participation lasts approximately 12 weeks.

CONDITIONS

Brief Title

Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome

Research Team

C

Chun-Yao Huang, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here